
FDA Updates COVID Vaccine Guidelines and Access
The FDA has narrowed Covid-19 vaccine approval to high-risk groups, but officials claim vaccines remain available to all. Experts warn that for healthy individuals under 65, access may be limited due to the need for off-label prescriptions, insurance issues, and logistical barriers, making true universal access unlikely. The situation is complicated further by state-specific regulations and the rescinding of emergency authorizations for certain age groups, raising concerns about equitable vaccine availability amid ongoing Covid-19 risks.

